412 related articles for article (PubMed ID: 29751760)
1. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
Kostuk EW; Cai J; Iacovitti L
J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
[TBL] [Abstract][Full Text] [Related]
2. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.
Kostuk EW; Cai J; Iacovitti L
Glia; 2019 Aug; 67(8):1542-1557. PubMed ID: 31025779
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
[TBL] [Abstract][Full Text] [Related]
4. EriB targeted inhibition of microglia activity attenuates MPP
Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP⁺ Neurotoxicity.
Baek JY; Jeong JY; Kim KI; Won SY; Chung YC; Nam JH; Cho EJ; Ahn TB; Bok E; Shin WH; Jin BK
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423807
[TBL] [Abstract][Full Text] [Related]
6. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Kuter K; Olech Ł; Głowacka U
Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
[TBL] [Abstract][Full Text] [Related]
7. Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress.
Park ES; Kim SR; Jin BK
Brain Res Bull; 2012 Nov; 89(3-4):92-6. PubMed ID: 22796104
[TBL] [Abstract][Full Text] [Related]
8. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors.
Jaumotte JD; Wyrostek SL; Zigmond MJ
Eur J Neurosci; 2016 Jul; 44(1):1691-9. PubMed ID: 27098376
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
eNeuro; 2017; 4(6):. PubMed ID: 29177188
[TBL] [Abstract][Full Text] [Related]
10. Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons.
Phani S; Jablonski M; Pelta-Heller J; Cai J; Iacovitti L
Brain Res; 2013 Mar; 1500():88-98. PubMed ID: 23348379
[TBL] [Abstract][Full Text] [Related]
11. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
Jung UJ; Jeon MT; Choi MS; Kim SR
J Med Food; 2014 May; 17(5):599-605. PubMed ID: 24660866
[TBL] [Abstract][Full Text] [Related]
12. Pro-Inflammatory Role of AQP4 in Mice Subjected to Intrastriatal Injections of the Parkinsonogenic Toxin MPP.
Prydz A; Stahl K; Zahl S; Skauli N; Skare Ø; Ottersen OP; Amiry-Moghaddam M
Cells; 2020 Nov; 9(11):. PubMed ID: 33167342
[TBL] [Abstract][Full Text] [Related]
13. Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.
Cipriani S; Desjardins CA; Burdett TC; Xu Y; Xu K; Schwarzschild MA
PLoS One; 2012; 7(5):e37331. PubMed ID: 22606360
[TBL] [Abstract][Full Text] [Related]
14. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
15. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.
Jeong KH; Jeon MT; Kim HD; Jung UJ; Jang MC; Chu JW; Yang SJ; Choi IY; Choi MS; Kim SR
J Med Food; 2015 Apr; 18(4):409-14. PubMed ID: 25325362
[TBL] [Abstract][Full Text] [Related]
18. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
[TBL] [Abstract][Full Text] [Related]
19. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease models.
Zhou J; Qu XD; Li ZY; Wei-Ji ; Liu Q; Ma YH; He JJ
PLoS One; 2014; 9(7):e101668. PubMed ID: 24991814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
